PWS
RMD icon

Peloton Wealth Strategists’s ResMed RMD Stock Holding History

Peloton Wealth Strategists’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,225
Closed -$509K – 98
2024
Q4 		$509K Sell
2,225
-1,960
-47% -$472K 0.21% 76
2024
Q3 		$1.02M Sell
4,185
-200
-5% -$44.7K 0.41% 66
2024
Q2 		$839K Sell
4,385
-975
-18% -$198K 0.35% 67
2024
Q1 		$1.06M Sell
5,360
-860
-14% -$158K 0.43% 64
2023
Q4 		$1.07M Sell
6,220
-165
-3% -$25.4K 0.46% 62
2023
Q3 		$944K Hold
6,385
– – 0.44% 64
2023
Q2 		$1.4M Buy
6,385
+150
+2% +$33.4K 0.62% 58
2023
Q1 		$1.36M Sell
6,235
-100
-2% -$21.7K 0.62% 56
2022
Q4 		$1.32M Buy
6,335
+125
+2% +$27.5K 0.64% 53
2022
Q3 		$1.36M Sell
6,210
-85
-1% -$19.3K 0.71% 50
2022
Q2 		$1.32M Sell
6,295
-200
-3% -$42.6K 0.64% 54
2022
Q1 		$1.57M Buy
6,495
+180
+3% +$43.5K 0.66% 56
2021
Q4 		$1.65M Buy
6,315
+80
+1% +$20.8K 0.66% 54
2021
Q3 		$1.64M Buy
6,235
+100
+2% +$27.3K 0.67% 54
2021
Q2 		$1.51M Buy
6,135
+300
+5% +$63.1K 0.62% 56
2021
Q1 		$1.13M Buy
+5,835
New +$1.17M 0.53% 57

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Peloton Wealth Strategists's RMD Position: Q1 2025 in Review

Peloton Wealth Strategists sold out of ResMed (RMD) in Q1 2025, closing a stake of 2,225 shares — an estimated $509K sold.

Peloton Wealth Strategists first reported a position in RMD in Q1 2021 and held it in 16 quarters. The position peaked at $1.65M in Q4 2021. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Peloton Wealth Strategists reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Peloton Wealth Strategists sold 2,225 ResMed shares in Q1 2025, an estimated $509K.
  • Peloton Wealth Strategists first reported a position in ResMed in Q1 2021 and held it in 16 quarters.
  • Peloton Wealth Strategists's ResMed position peaked at $1.65M in Q4 2021.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Peloton Wealth Strategists's 13F filing for Q1 2025, filed 16 May 2025.